This course has expired. View available courses.

Medication, Medication Management

Value in Multiple Sclerosis Management and Specialty Pharmaceuticals (CAN)

Pharmacoeconomics has been used, in various ways, at the institutional level, for formulary decision making around specialty pharmaceuticals. This program reviews the role of pharmacoeconomics and cost-effectiveness thresholds, along with mechanisms that influence and affect drug policy listing decisions.


DURATION

1 hr

PROFESSION

Pharmacy

# OF CREDITS

1

ACCREDITATION

CCCEP

EXPIRY DATE

2024-03-25

Pharmacoeconomics has been used, in various ways, at the institutional level, for formulary decision making around specialty pharmaceuticals. This program reviews the role of pharmacoeconomics and cost-effectiveness thresholds, along with mechanisms that influence and affect drug policy listing decisions.


This program is supported by Pharmascience

Faculty

Ahmad Alghamdi, Pharm D., Ph.D, HEOR
Consultant, Assistant Professor of Pharmaceutical Economics & Policy
President of the Saudi Pharmacoeconomics Experts Group
A researcher and assistant professor with a demonstrated history of working in the higher education industry. Dr. Alghamdi is a PhD holder in Pharmaceutical Economics and Policy.

Hana Al-Abdulkarim, BSc, MSc, HEOR, MSc
Director, Drug Policy and Economic Center, Ministry of National Guard Health Affairs, Riyadh, KSAH.

Moe Abdallah, B.SC., B.SC.PHM., R.PH
Clinical pharmacist, Drug Programs Policy and Strategy Branch
Ontario Public Drug Programs
Ministry of Health and Long-Term Care

Michael Boivin, RPh, BScPhm
Clinical Pharmacist Consultant and Continuing Education Developer

Learning objectives

After viewing this webinar, participants will be better able to:

  • Explain the key principles of value and value-based healthcare.
  • Apply the principles of value-based healthcare to multiple sclerosis (MS) management.
  • Describe the elements of determining value for specialty pharmaceuticals.
  • Discuss the benefits provided by patient support programs (PSPs) and their relevance in the assessment of value of specialty pharmaceuticals.

Accreditation

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.00 CEUs.

CCCEP File Number:  1066-2022-3395-I-P


Cost of course:  
Free
# of credits: 1
Duration: 1 hr

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.

Value in Multiple Sclerosis Management and Specialty Pharmaceuticals (CAN)

1 hr

Duration

Pharmacy

Profession

1

# of credits

Learning Objectives

After viewing this webinar, participants will be better able to:

  • Explain the key principles of value and value-based healthcare.
  • Apply the principles of value-based healthcare to multiple sclerosis (MS) management.
  • Describe the elements of determining value for specialty pharmaceuticals.
  • Discuss the benefits provided by patient support programs (PSPs) and their relevance in the assessment of value of specialty pharmaceuticals.

CCCEP

ACCREDITATION

Medication, Medication Management

Learning Category

Pharmacoeconomics

Topic

0

Price

2024-03-25

Expiry Date

CAN-eng

Region/Language

Course Description

Pharmacoeconomics has been used, in various ways, at the institutional level, for formulary decision making around specialty pharmaceuticals. This program reviews the role of pharmacoeconomics and cost-effectiveness thresholds, along with mechanisms that influence and affect drug policy listing decisions.


This program is supported by Pharmascience

Faculty

Ahmad Alghamdi, Pharm D., Ph.D, HEOR
Consultant, Assistant Professor of Pharmaceutical Economics & Policy
President of the Saudi Pharmacoeconomics Experts Group
A researcher and assistant professor with a demonstrated history of working in the higher education industry. Dr. Alghamdi is a PhD holder in Pharmaceutical Economics and Policy.

Hana Al-Abdulkarim, BSc, MSc, HEOR, MSc
Director, Drug Policy and Economic Center, Ministry of National Guard Health Affairs, Riyadh, KSAH.

Moe Abdallah, B.SC., B.SC.PHM., R.PH
Clinical pharmacist, Drug Programs Policy and Strategy Branch
Ontario Public Drug Programs
Ministry of Health and Long-Term Care

Michael Boivin, RPh, BScPhm
Clinical Pharmacist Consultant and Continuing Education Developer

Accreditation

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.00 CEUs.

CCCEP File Number:  1066-2022-3395-I-P